Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 33
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Kim K, Tarr GAM, Chui L, Drews S, Pang X-L, Lee BE, Ali S, Nettel-Aguirre A, Vanderkooi OG, Berenger BM, Dickinson J, Tarr PI, MacDonald J, Freedman SB | 2018 | Clin Infect Dis | View Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Health care providers | Clinical research |
Severe autoimmune LMWH-induced thrombocytopenia presenting with aortic thromboses, adrenal hemorrhage and pulmonary embolism: response to high-dose intravenous immunoglobulin | Nero J, Araneta P, Warkentin T, Moodley O | 2018 | Can J Gen Intern Med | View Severe autoimmune LMWH-induced thrombocytopenia presenting with aortic thromboses, adrenal hemorrhage and pulmonary embolism: response to high-dose intravenous immunoglobulin | Health care providers | Clinical research |
Concentrés pour les troubles de l'hémostase et l'angioedéme héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Concentrés pour les troubles de l'hémostase et l'angioedéme héréditaire | Health care providers | Benchmarking and standard setting |
Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease | Tse E, Khurana R, Clarke G, Sia W | 2018 | Obstet Med | View Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease | Health care providers | New or improved product or process |
A retrospective study of the added value of parallel titers compared with serial titers | Lin Y, Cohen R, Buckstein J, Callum J, Lieberman L | 2019 | Transfusion | View A retrospective study of the added value of parallel titers compared with serial titers | Health care providers | Clinical research |
Blood System Inventory Management Best Practices Guide | Clarke G, Romans R | 2020 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Concentré de recherche: Estimation de la prévalence de l’hémophilie et de l’espérance de vie | Iorio A | 2020 | Blood.ca website | Health care providers | Clinical research | |
Effects of the COVID-19 pandemic on supply and use of blood for transfusion | Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, Germain M, Goldman M, Massey E, Prati D, Shehata N, So-Osman C, Thachil J | 2020 | Lancet Haematol | View Effects of the COVID-19 pandemic on supply and use of blood for transfusion | Health care providers | Clinical research |
Thrombotic Thrombocytopenic Purpura | Crowther M, Zawilska K, Mlynarski W, Arnold D | 2020 | McMaster Textbook of Internal Medicine | Health care providers | Benchmarking and standard setting | |
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Writing Committee for the REMAP-CAP Investigators | 2021 | JAMA | View Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Health care providers | Clinical research |
Concentré de recherche: Précision et efficacité accrues dans la gestion des réserves de sang | Li N | 2021 | Blood.ca website | View Concentré de recherche: Précision et efficacité accrues dans la gestion des réserves de sang | Health care providers | New or improved product or process |
Examining prescribing practices with respect to oral iron supplementation for post-partum anemia: a retrospective review | Iancu AM, Buckstein J, Melamed N, Lin Y | 2021 | J Matern Fetal Neonatal Med | View Examining prescribing practices with respect to oral iron supplementation for post-partum anemia: a retrospective review | Health care providers | Clinical research |
Chapter 4: Clinical transfusion procedures | Clarke G, Al-Riyami AZ, Roxby D | 2021 | Educational Modules on Clinical Use of Blood | View Chapter 4: Clinical transfusion procedures | Health care providers | Benchmarking and standard setting |
ResearchUnit: Platelet Transfusion in Children with Cancer | Barty R | 2021 | Blood.ca website | View ResearchUnit: Platelet Transfusion in Children with Cancer | Health care providers | Benchmarking and standard setting |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
Best practices in the differential diagnosis and reporting of acute transfusion reactions | Heddle N, Hillis C, Shih A | 2016 | Internat J Clin Transfus Med | View Best practices in the differential diagnosis and reporting of acute transfusion reactions | Health care providers | Clinical research |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Jenkins C | 2015 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC), Cord Blood | Health care providers | Benchmarking and standard setting |
Donor selection, transmissible disease testing and pathogen reduction | Goldman M, Scalia V, Devine D | 2017 | Clinical Guide to Transfusion | View Donor selection, transmissible disease testing and pathogen reduction | Health care providers | Other |
Fractionated blood products and associated pathogen safety | Bigham M | 2017 | Clinical Guide to Transfusion | View Fractionated blood products and associated pathogen safety | Health care providers | Other |
Mechanisms of action and immunomodulation by IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Mechanisms of action and immunomodulation by IVIg | Health care providers | Other |
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015 | Flegel WA, Castilho L, Heaton WA, Keller MA, Klapper EB, Lane WJ, Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Wagner FF, Waxman DA, Denomme GA | 2016 | Transfusion | View Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015 | Health care providers | Clinical research |
Novel treatments for immune thrombocytopenia | Shih A, Nazi I, Kelton JG, Arnold DM | 2014 | Presse Med | View Novel treatments for immune thrombocytopenia | Health care providers | Clinical research |
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM | 2015 | Lancet Haematol | View Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Health care providers | Clinical research |
The importance of haemophilia treatment centre administrators in patient care | Almonte T, Decker K, Seroski W, Walker I, Webert K, Bos C, Strike K, Waterhouse L, Goldsmith R, Chan AK | 2012 | Haemophilia | View The importance of haemophilia treatment centre administrators in patient care | Health care providers | Other |
The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing | Cembrowski G, Topping K, Versluys K, Tran D, Malick M, Holmes D, Clarke G | 2015 | Int J Lab Hematol | View The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing | Health care providers | New or improved product or process |
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion | Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC | 2016 | Cochrane Database Syst Rev | View Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion | Health care providers | Clinical research |
Albumine | Clarke G, Yan M | 2018 | Guide de la pratique transfusionnelle | View Albumine | Health care providers | Other |
Bonnes pratiques en matière de transfusion de plaquettes | Romans R | 2019 | Blood.ca website | View Bonnes pratiques en matière de transfusion de plaquettes | Health care providers | Benchmarking and standard setting |
Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Shih AW, Morrison D, Sekhon AS, Lin Y, Charge S, Chipperfield K, Beaveridge J | 2020 | Transfusion | View Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Health care providers | Other |
Influenza increases invasive meningococcal disease risk in temperate countries | Salomon A, Berry I, Tuite AR, Drews S, Hatchette T, Jamieson F, Johnson C, Kwong J, Lina B, Lojo J, Mosnier A, Ng V, Vanhems P, Fisman DN | 2020 | Clin Microbiol Infect | View Influenza increases invasive meningococcal disease risk in temperate countries | Health care providers | Clinical research |
Platelet clinical best practices | Romans R | 2019 | Blood.ca website | View Platelet clinical best practices | Health care providers | Benchmarking and standard setting |
Surveillance Report 2018 | O'Brien S | 2019 | Blood.ca website | View Surveillance Report 2018 | Health care providers | Benchmarking and standard setting |
COVID-19 versus HIT hypercoagulability | Warkentin TE, Kaatz S | 2020 | Thromb Res | View COVID-19 versus HIT hypercoagulability | Health care providers | Clinical research |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ | 2020 | Blood Adv | View Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Health care providers | Clinical research |
Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Obaidallah N, Downie H, Colavecchia C, Callum J, Lin Y | 2022 | Transfusion | View Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Health care providers | New or improved product or process |
ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? | Kron A | 2021 | Blood.ca website | View ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? | Health care providers | Clinical research |
Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider | El-Khoury H, Saifi O, Haddad S, Chahrour M, Ghanem KM, Mubarak Y, Tamim H, Makki M, Zakka C, Chan AK, Mahfouz R, Tarek N, El-Solh H, Abboud MR, Saab R, Muwakkit SA | 2021 | Pediatr Blood Cancer | View Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider | Health care providers | Clinical research |
Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology | Al-Samkari H, Cronin A, Arnold DM, Rodeghiero F, Grace RF | 2021 | J Thromb Haemost | View Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology | Health care providers | Benchmarking and standard setting |
FAQ: Information for health professionals on pathogen-reduced platelets | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ: Information for health professionals on pathogen-reduced platelets | Health care providers | New or improved product or process |
A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME) | Webert KE, Arnold DM, Lui Y, Carruthers J, Arnold E, Heddle NM | 2012 | Transfusion | View A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME) | Health care providers | Clinical research |
Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes | Michelis FV, Branch DR, Scovell I, Bloch E, Pendergrast J, Lipton JH, Cserti-Gazdewich CM | 2014 | Transfusion | View Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes | Health care providers | Clinical research |
Blood and clots quizlet 2: Trauma in a patient on warfarin | Shih A, Tseng E, de Wit K, Chan T | 2017 | CanadiEM website | View Blood and clots quizlet 2: Trauma in a patient on warfarin | Health care providers | Benchmarking and standard setting |
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review | Warkentin TE, Pai M, Linkins LA | 2017 | Blood | View Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review | Health care providers | Clinical research |
Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data | Knoll GA, Kokolo MB, Mallick R, Beck A, Buenaventura CD, Ducharme R, Barsoum R, Bernasconi C, Blydt-Hansen TD, Ekberg H, Felipe CR, Firth J, Gallon L, Gelens M, Glotz D, Gossmann J, Guba M, Morsy AA, Salgo R, Scheuermann EH, Tedesco-Silva H, Vitko S, Watson C, Fergusson DA | 2014 | BMJ | View Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data | Health care providers | Clinical research |
Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH | Iorio A, Blanchette V, Blatny J, Collins P, Fischer K, Neufeld E | 2017 | J Thromb Haemost | View Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH | Health care providers | Clinical research |
Gestational hypertension and preeclampsia in living kidney donors | Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand C, Monroy-Cuadros M, Lentine KL | 2015 | N Engl J Med | View Gestational hypertension and preeclampsia in living kidney donors | Health care providers | Clinical research |
Pitfalls in the diagnosis of heparin-induced thrombocytopenia: A 6-year experience from a reference laboratory | Nazi I, Arnold DM, Moore JC, Smith JW, Ivetic N, Horsewood P, Warkentin TE, Kelton JG | 2015 | Am J Hematol | View Pitfalls in the diagnosis of heparin-induced thrombocytopenia: A 6-year experience from a reference laboratory | Health care providers | Clinical research |
Red Blood Cell Storage Lesions and Related Transfusion Issues: A Canadian Blood Services Research and Development Symposium | Pavenski K, Saidenberg E, Lavoie M, Tokessy M, Branch DR | 2012 | Transfus Med Rev | View Red Blood Cell Storage Lesions and Related Transfusion Issues: A Canadian Blood Services Research and Development Symposium | Health care providers | Other |
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support | Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF | 2017 | Cochrane Database Syst Rev | View Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support | Health care providers | Clinical research |
Serological best practices: Anti-M | Clarke G, Cote J, Lane D | 2017 | Blood.ca website | View Serological best practices: Anti-M | Health care providers | Benchmarking and standard setting |